Wellington Management Group’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Sell
248,158
-9,113
-4% -$38.7K ﹤0.01% 1721
2025
Q4
$929K Sell
257,271
-7,531
-3% -$32.8K ﹤0.01% 1725
2025
Q3
$998K Buy
264,802
+12,936
+5% +$49.9K ﹤0.01% 1779
2025
Q2
$975K Buy
251,866
+26,912
+12% +$146K ﹤0.01% 1728
2025
Q1
$1.12M Buy
224,954
+19,721
+10% +$125K ﹤0.01% 1680
2024
Q4
$1.48M Buy
205,233
+8,001
+4% +$61.1K ﹤0.01% 1646
2024
Q3
$1.21M Buy
197,232
+42,553
+28% +$288K ﹤0.01% 1673
2024
Q2
$1.03M Sell
154,679
-2,235
-1% -$16.5K ﹤0.01% 1665
2024
Q1
$1.6M Buy
+156,914
New +$1.6M ﹤0.01% 1577
2017
Q1
Sell
-160
Closed -$156K 2235
2016
Q4
$156K Buy
+160
New +$143K ﹤0.01% 2152

Other funds holding ALT

Wellington Management Group's ALT Position: Q1 2026 in Review

Wellington Management Group reduced its Altimmune (ALT) stake by 3.5% in Q1 2026, selling an estimated $38.7K and leaving 248,158 shares worth $764K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Wellington Management Group first reported a position in ALT in Q4 2016 and has held it in 10 quarters since. The position peaked at $1.6M in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Wellington Management Group held 248,158 shares of Altimmune worth $764K as of Q1 2026.
  • Wellington Management Group sold 9,113 Altimmune shares in Q1 2026, an estimated $38.7K.
  • Altimmune made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1721 holding.
  • Wellington Management Group first reported a position in Altimmune in Q4 2016 and has held it in 10 quarters since.
  • Wellington Management Group's Altimmune position peaked at $1.6M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.